Form 4: Quanterix Director Granted 46,727 Restricted Stock Units

Quanterix Corp Director Malcolm Garret Hampton received a grant of 46,727 restricted stock units, vesting over three years.

Summary

• Malcolm Garret Hampton, a Director of Quanterix Corp (QTRX), was granted 46,727 shares of common stock in the form of Restricted Stock Units (RSUs).
• The transaction date for this acquisition was November 20, 2025.
• The RSUs will vest in three equal installments: one-third on November 20, 2026, one-third on November 20, 2027, and the final one-third on November 20, 2028.
• Vesting is contingent upon Mr. Hampton's continued provision of service to Quanterix Corporation on each respective vesting date.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it represents a standard compensation practice that aligns the interests of a director with shareholders, without indicating any negative operational or financial news.

Positives

• The grant of Restricted Stock Units to a director aligns their financial interests with those of the company's shareholders, encouraging long-term value creation.
• This form of equity compensation is a standard practice for retaining and incentivizing key personnel and board members.

Risks

• The vesting of the RSUs is subject to the reporting person's continued service to the Issuer on each vesting date, meaning the shares are not guaranteed if service ceases.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's financial performance or strategic direction, focusing solely on an insider compensation event.

Industry Context

The grant of restricted stock units to a director is a common form of executive and board compensation across various industries, particularly in technology and life sciences, aiming to align leadership incentives with long-term company performance and shareholder value.

Comparison to Industry Standards

• Granting equity compensation, such as RSUs, to non-employee directors is a widely accepted practice in corporate governance, comparable to compensation structures seen at companies like Illumina or Bio-Rad Laboratories, which also utilize equity to incentivize board members.
• The multi-year vesting schedule is typical for such grants, promoting long-term commitment and discouraging short-term decision-making, consistent with best practices in director compensation across the S&P 500.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially fostering decisions that enhance long-term shareholder value.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The RSUs will vest in three annual installments on November 20, 2026, November 20, 2027, and November 20, 2028, subject to continued service.

Key Dates

Keywords

Quanterix Corp, QTRX, Restricted Stock Units, RSU grant, insider transaction, director compensation, equity compensation, Form 4, SEC filing